Of the 485 candidate SNVs and indels (Supplement Table S4), mutation of four genes (TP53, MYD88, PIM1, and B2M) that relate to the major driver genes in DLBCL [16, 17] were shared by three of 13 patients (23.1%). This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.